Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Takeda seeks US FDA nod for fixed dose combo of azilsartan medoxomil plus chlorthalidone to treat hypertension
Takeda seeks US FDA nod for fixed dose combo of azilsartan medoxomil plus chlorthalidone to treat hypertension
Takeda seeks US FDA nod for fixed dose combo of azilsartan medoxomil plus chlorthalidone to treat hypertension
Submitted by
admin
on February 26, 2011 - 11:12am
Source:
pharmabiz
News Tags:
Takeda
azilsartan medoxomil plus chlorthalidone
hypertension
antihypertensives
Headline:
Takeda seeks US FDA nod for fixed dose combo of azilsartan medoxomil plus chlorthalidone to treat hypertension
Do Not Allow Advertisers to Use My Personal information